Last updated on March 2016

A Phase 2b, Randomized, Doubl-blind, Placebo-controlled, Parallel-group, Dose-ranging-finding Trial of XXXXX Administered Orally for 8 Weeks to Patients with Symptomatic Gastroesophageal Reflux Disease Not Completely Responsive to Proton Pump Inhibitors


Find a site near you

Start Over

IMA Research

80-02 Kew Gardens Road, Suite 102 Kew Gardens, NY USA
  Connect »